GLP-1 (Glucagon-like Peptide-1) receptor agonists are a class of medications that mimic a hormone in your body to: Slow down gastric emptying (you feel full longer) Suppress appetite (less food, less snacking) Improve insulin sensitivity and blood sugar level s Originally developed for type 2 diabetes, GLP-1s are now widely prescribed for weight loss and metabolic health
Interestingly, co-administration of coenzyme Q 10 with remacemide (an NMDA receptor antagonist), the antibiotic minocycline, or creatine led to greater improvements in most biochemical and behavioral parameters (70-72)
Fat Metabolism Assists in shrinking fat deposits in the abdominal and hip areas
Anterior cingulate theta activity is associated with degree of treatment response in major depression
Younger consumers, particularly millennials and Gen Z, are driving adoption of anti-aging treatments, immune-supporting supplements, and detoxification products as part of comprehensive wellness strategies, while simultaneously, aging populations are seeking preventive solutions to address chronic disease risk and age-related decline
Oncogene 38 , 42324249 (2019)